ICU Medical Q2 GAAP net income falls 46% to USD 19.1 million; revenue rises 1% to USD 551.7 million - ICUI News | RalliesICU Medical Q2 GAAP net income falls 46% to USD 19.1 million; revenue rises 1% to USD 551.7 million
I
ICUI• Second-quarter results
- ICU Medical posted second-quarter GAAP net income of USD 19.1 million, down from USD 35.3 million a year earlier; diluted EPS fell to USD 0.76.
- GAAP revenue edged up 1% from a year earlier to USD 551.7 million; GAAP gross margin widened 5 percentage points to 43%.
- Adjusted EBITDA rose to USD 110 million from USD 100.3 million, while adjusted diluted EPS increased to USD 2.37 from USD 2.10.
Management commentary and guidance
- CEO Vivek Jain said Infusion Systems results were ahead of expectations, with the remainder of the business generally in line with expectations.
- Fiscal 2026 guidance was raised for GAAP net income to USD 73 million–USD 83 million and adjusted EBITDA to USD 415 million–USD 435 million.
